INOS ablation does not improve specific force of the extensor digitorum longus muscle in dystrophin-deficient mdx4cv mice

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Li, Dejia ^a,b   Shin, Jin Hong ^a   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXTENSOR DIGITORUM LONGUS MUSCLE; HISTOPATHOLOGY; MDX4CV MOUSE; MOUSE; MOUSE STRAIN; MUSCLE FORCE; MUSCLE TETANIC CONTRACTION; MUSCLE TWITCH; NITROSATIVE STRESS; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; DUCHENNE MUSCULAR DYSTROPHY; GENETICS; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; SKELETAL MUSCLE;

MUS;

ANIMALS; DYSTROPHIN; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 79959745943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021618     Document Type: Article

References (43)

1. Romitti P, Mathews K, Zamba G, Andrews J, Druschel C, et al. (2009) Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years- four states, 2007. MMWR Morb Mortal Wkly Rep 58: 1119-1122.
2. Kunkel LM, (2005) 2004 William Allan Award address. Cloning of the DMD gene. Am J Hum Genet 76: 205-214.
3. Goldstein JA, McNally EM, (2010) Mechanisms of muscle weakness in muscular dystrophy. J Gen Physiol 136: 29-34.
4. Petrof BJ, (2002) Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am J Phys Med Rehabil 81: S162-174.
5. Batchelor CL, Winder SJ, (2006) Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy. Trends Cell Biol 16: 198-205.
6. Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, et al. (2009) Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med 15: 325-330.
7. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, et al. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228.
8. Nathan C, Xie QW, (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915-918.
9. Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG, (2009) Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 18: 482-496.
10. Louboutin JP, Rouger K, Tinsley JM, Halldorson J, Wilson JM, (2001) iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin. Mol Med 7: 355-364.
11. Bia BL, Cassidy PJ, Young ME, Rafael JA, Leighton B, et al. (1999) Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J Mol Cell Cardiol 31: 1857-1862.
12. Bellinger AM, Mongillo M, Marks AR, (2008) Stressed out: the skeletal muscle ryanodine receptor as a target of stress. J Clin Invest 118: 445-453.
13. Shin J-H, Hakim C, Zhang K, Duan D, (2011) Genotyping mdx, mdx3cv and mdx4cv mice by primer competition PCR. Muscle Nerve 43: 283-286.
14. Li D, Yue Y, Lai Y, Hakim CH, Duan D, (2011) Nitrosative stress elicited by nNOSmicro delocalization inhibits muscle force in dystrophin-null mice. J Pathol 223: 88-98.
15. Lai Y, Thomas GD, Yue Y, Yang HT, Li D, et al. (2009) Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 119: 624-635.
16. Li D, Bareja A, Judge L, Yue Y, Lai Y, et al. (2010) Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci 123: 2008-2013.
17. Saito A, Seiler S, Chu A, Fleischer S, (1984) Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J Cell Biol 99: 875-885.
18. Forrester MT, Thompson JW, Foster MW, Nogueira L, Moseley MA, et al. (2009) Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat Biotechnol 27: 557-559.
19. Hainsey TA, Senapati S, Kuhn DE, Rafael JA, (2003) Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature. Neuromuscul Disord 13: 294-302.
20. Amthor H, Egelhof T, McKinnell I, Ladd ME, Janssen I, et al. (2004) Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI. Neuromuscul Disord 14: 791-796.
21. Smith BF, Yue Y, Woods PR, Kornegay JN, Shin JH, et al. (2011) An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed. Lab Invest 91: 216-231.
22. Yue Y, Ghosh A, Long C, Bostick B, Smith BF, et al. (2008) A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol Ther 16: 1944-1952.
23. Li D, Long C, Yue Y, Duan D, (2009) Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum Mol Genet 18: 1209-1220.
24. Bostick B, Yue Y, Long C, Marschalk N, Fine DM, et al. (2009) Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Ther 17: 253-261.
25. Liu M, Yue Y, Harper SQ, Grange RW, Chamberlain JS, et al. (2005) Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol Ther 11: 245-256.
26. Lai Y, Yue Y, Liu M, Ghosh A, Engelhardt JF, et al. (2005) Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat Biotechnol 23: 1435-1439.
27. Yue Y, Liu M, Duan D, (2006) C-terminal truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double knock-out mice. Mol Ther 14: 79-87.
28. Li D, Yue Y, Duan D, (2008) Preservation of muscle force in mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein. Am J Pathol 172: 1332-1341.
29. Thompson M, Becker L, Bryant D, Williams G, Levin D, et al. (1996) Expression of the inducible nitric oxide synthase gene in diaphragm and skeletal muscle. J Appl Physiol 81: 2415-2420.
30. Li S, Kimura E, Ng R, Fall BM, Meuse L, et al. (2006) A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy. Hum Mol Genet 15: 1610-1622.
31. Laubach VE, Shesely EG, Smithies O, Sherman PA, (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 92: 10688-10692.
32. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, et al. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase [published erratum appears in Cell 1995 Jun 30;81(7):following 1170]. Cell 81: 641-650.
33. Perreault M, Marette A, (2001) Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7: 1138-1143.
34. Jackson MJ, Pye D, Palomero J, (2007) The production of reactive oxygen and nitrogen species by skeletal muscle. J Appl Physiol 102: 1664-1670.
35. Stamler JS, Meissner G, (2001) Physiology of nitric oxide in skeletal muscle. Physiol Rev 81: 209-237.
36. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS, (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82: 743-752.
37. Chao DS, Gorospe JR, Brenman JE, Rafael JA, Peters MF, et al. (1996) Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 184: 609-618.
38. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, et al. (1998) Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A 95: 15090-15095.
39. Webster C, Silberstein L, Hays AP, Blau HM, (1988) Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52: 503-513.
40. Moens P, Baatsen PH, Marechal G, (1993) Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch [see comments]. J Muscle Res Cell Motil 14: 446-451.
41. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, et al. (1992) Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 176: 599-604.
42. Schmidt HH, Pollock JS, Nakane M, Forstermann U, Murad F, (1992) Ca2+/calmodulin-regulated nitric oxide synthases. Cell Calcium 13: 427-434.
43. Allen DG, Gervasio OL, Yeung EW, Whitehead NP, (2010) Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol 88: 83-91.